 CAMBRIDGE, Mass., Nov. 20, 2020 PRNewswire -- Cogent Biosciences, Inc. Nasdaq: COGT, a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will participate in a... 